Skip to main content
Premium Trial:

Request an Annual Quote

BD Biosciences Licenses Proteomics Technology from Stanford

NEW YORK, Dec. 17 - BD Biosciences today said it has licensed certain proteomics technology from Stanford University.


BD it will use the technology, which is awaiting patent protection, in its flow-cytometry research in order to create new assays and study cellular pathways, the company said.

The technology was developed by Stanford researchers Garry Nolan and Omar Perez.


No further information was provided.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.